Statement pursuant to SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 for the financial year ended March 31, 2024
Sl. | Particulars | Employee Stock Option Plan, 2006 |
No. | ("ESOP, 2006") | |
1 | Date of | shareholders' July 5, 2006 |
approval |
- Total number of options Total number of options shall not
approved under Employee | exceed 5% of the total paid up equity | ||||
Stock Option | Plan, | 2006 | shares of the Company from time to | ||
and Restricted | Stock | Unit | time. Paid up equity shares | of the | |
Plan, 2019 | Company as at March 31, 2024 are | ||||
27,38,05,630. | Accordingly, | the |
maximum no. of options that can be granted by the Company is 1,36,90,281 (5% of 27,38,05,630) as on March 31, 2024.
Restricted Stock Unit Plan, 2019 ("RSU,
2019")
August 1, 2019
Total number of options shall not exceed 1% of the total paid up equity shares of the Company from time to time. Paid up equity shares of the Company as at March 31, 2024 are 27,38,05,630. Accordingly, the maximum no. of options that can be granted by the Company is 27,38,056 (1% of 27,38,05,630) as on March 31, 2024.
- Vesting Requirements
- Exercise price or pricing formula
- Maximum term of options granted
- Source of shares (primary, secondary or combination)
- Variation in terms of options
- Method used to account for ESOS - Intrinsic or fair value
Vesting of the options shall take place in the manner determined by the Nomination and Remuneration Committee at the time of grant provided the vesting period shall not be less than 1 (one) year from the date of grant.
Vesting of options shall be subject to the conditions that the Grantee shall be in continuous employment with the Company and such other conditions and exceptions as provided under Company's ESOP, 2006 and RSU, 2019.
The Exercise Price of each grant is | The Exercise Price of each grant shall be |
determined by the Nomination and | the face value of the Share on the date of |
Remuneration Committee at the time | exercise of RSU. |
of grant, provided that the Exercise | |
Price shall not be less than the closing | |
market price of the shares of the | |
Company on NSE/BSE on the day | |
preceding the date of grant of Options. |
The maximum term of options granted within which they shall be exercised is decided by the Nomination and Remuneration Committee which is generally ten years from the date of grant of the options.
Primary
During the year, no amendment/ modification/ variation has been made in terms
of options granted by the Company. | |
Equity-settledshare-based payments | Equity-settledshare-based payments to |
to employees are measured at the fair | employees are measured at the fair value |
value of the equity instruments at the | of the equity instruments at the grant |
grant date. The fair value determined | date. The fair value determined at the |
at the grant date of the equity-settled | grant date of the equity-settled share- | ||||||
share-based payments is expensed on | based payments is expensed on a | ||||||
a straight-line basis over the vesting | straight-line basis over the vesting period. | ||||||
period. The cost (net of reversal, due | The cost (net of reversal, due to | ||||||
to forfeiture) of share-based payments | forfeiture) of share-based payments to | ||||||
to employees for the year ended | employees for the year ended March 31, | ||||||
March 31, 2024 is Rs. 9.98 crores. | 2024 is Rs. 24.24 crores. | ||||||
9 | Where | the | company | opts | Not Applicable | Not Applicable | |
for expensing of the options | |||||||
using the intrinsic value of | |||||||
the options, the difference | |||||||
between | the | employee | |||||
compensation | cost | so | |||||
computed | and | the | |||||
employee | compensation | ||||||
cost that shall have been | |||||||
recognised if it had used the | |||||||
fair value of the options | |||||||
shall | be | disclosed. | The | ||||
impact of this difference on | |||||||
profits and on EPS of the | |||||||
company | shall | also | be | ||||
disclosed. |
10 Weighted-average exercise Details of weighted average exercise Details of weighted average exercise
prices | and | weighted- | prices and weighted average fair | prices and weighted average fair values | |||||
average | fair values of | values of the options exercised during | of the options exercised during the | ||||||
options | shall | be | disclosed | the financial year ended March 31, | financial year ended March 31, 2024, | ||||
separately | for | options | 2024, whose exercise price equals to | whose exercise price is less than the | |||||
whose exercise price either | the market price of the stock on the | market price of the stock on the date of | |||||||
equals or exceeds or is less | date of grant: | grant: | |||||||
than the market price of the | Weighted | average | exercise | price | - | Weighted average exercise price - Re. 1 | |||
stock. | |||||||||
Rs. 1,437.08 | |||||||||
Weighted average fair value - Rs. Nil | |||||||||
Weighted | average | fair | value | - | |||||
Rs. 524.72 |
11 Details of Options granted during the financial year ended March 31, 2024
i) | Director | None | Options granted to 1 (one) Director | |
during the financial year at an exercise | ||||
price of Re. 1. | ||||
ii) | Senior | Managerial | None | 33,300 options granted to 11 (eleven) |
Personnel | Senior Managerial Personnel during the |
financial year at an exercise price of Re. 1. | ||||||||||||
iii) | Any | other | employee | None | Apart from information stated at point | |||||||
who received a grant in | 11(i) above on grant of stock options to a | |||||||||||
any one year of Options | Director, there is no grant to any other | |||||||||||
amounting | to | 5% | or | employee which is more than 5% of the | ||||||||
more | of | the | Options | total options granted during the financial | ||||||||
granted | during | that | year. | |||||||||
year. | ||||||||||||
iv) | Identified | employees | None | |||||||||
who | were | granted | ||||||||||
Options during any one | ||||||||||||
year, | equal | to | or | |||||||||
exceeding | 1% | of | the | |||||||||
issued | capital | |||||||||||
(excluding | outstanding | |||||||||||
warrants | and | |||||||||||
conversions) | of | the | ||||||||||
Company at the time of | ||||||||||||
grant. | ||||||||||||
12 | A description of the method | No ESOP grants during the | The fair value of each restricted stock unit granted | |||||||||
and significant assumptions | financial year ended March | during the year is estimated using the Black-Scholes | ||||||||||
used during the year to | 31, 2024. | Option Pricing Model after applying the following | ||||||||||
estimate the fair value of | key assumptions: | |||||||||||
options | including | the | ||||||||||
following information: | ||||||||||||
Option grant date | - | May 10, 2023 | August 3, 2023 | November 10, | ||||||||
2023 | ||||||||||||
(a) | (i) | the | weighted-average | - | 3381.90 | 3332.70 | 3541.90 | |||||
values of share price | ||||||||||||
(ii) exercise price | - | 1.00 | 1.00 | 1.00 | ||||||||
(iii) expected volatility | - | 29.52% | 28.61% | 27.41% | ||||||||
(iv) expected option life | - | 3 years | 3 years | 3 years | ||||||||
(v) expected dividends | - | 0.6013% | 0.6476% | 0.6476% | ||||||||
(vi) the risk-free interest | - | 7.09% | 7.23% | 7.39% | ||||||||
rate | ||||||||||||
(b) | the method used and the | Not Applicable | ||||||||||
assumptions | made | to | ||||||||||
incorporate the effects of | ||||||||||||
expected early exercise | ||||||||||||
(c) | how | expected | Volatility | Not Applicable | Expected Volatility was determined by taking the | |||||||
was | determined, | including | daily volatility of the share price on NSE, over a |
an explanation | of | the | period prior to the date of grant, corresponding to | |||||
extent | to | which | expected | the expected life of the options for each vesting. | ||||
volatility | was | based | on | |||||
historical volatility | ||||||||
(d) | whether and how any other | Not Applicable | ||||||
features of the option grant | ||||||||
were incorporated into the | ||||||||
measurement of fair value, | ||||||||
such as a market condition. | ||||||||
13 | Diluted | EPS on | issue | of | Rs. 136.75 | |||
shares pursuant to all | the | |||||||
schemes | covered under | |||||||
the regulations | shall | be | ||||||
disclosed | in | accordance | ||||||
with | 'Indian | Accounting | ||||||
Standard 33 -Earnings Per | ||||||||
Share' issued by ICAI or any | ||||||||
other | relevant | accounting | ||||||
standards | as | prescribed | ||||||
from time to time | ||||||||
14 | Relevant | disclosures | in All relevant disclosures have been made in the financial statements. | |||||
terms | of | the' | Guidance | |||||
note | on | accounting | for | |||||
employee | share-based | |||||||
payments' issued by ICAI or | ||||||||
any | other | relevant | ||||||
accounting | standards | as | ||||||
prescribed | from | time | to | |||||
time |
Details of Option Movement during the Financial Year 2023-24 | |||
Sl. No. | Particulars | Employee Stock Options | Restricted Stock Units |
Plan, 2006 | Plan, 2019 | ||
1. | Number of options outstanding at the | 9,38,190 | 1,37,880 |
beginning of the year | |||
2. | Number of options granted during the year | Nil | 1,49,250 |
3. | Number of options forfeited / lapsed | 24,000 | 11,400 |
during the year | |||
4. | Number of options vested during the year | 3,37,000 | Nil |
5. | Number of options exercised during the | 3,24,060 | Nil |
year | |||
6. | Number of shares arising as a result of | 3,24,060 | Nil |
exercise of options | |||
7. | Money realized by exercise of options | 46.57 Crores | Nil |
(INR), if scheme is implemented directly by | |||
the Company | |||
8. | Loan repaid by the Trust during the year | Not Applicable | Not Applicable |
from exercise price received | |||
9. | Number of options outstanding at the end | 5,90,130 | 2,75,730 |
of the year | |||
10. | Number of options exercisable at the end | 1,54,130 | Nil |
of the year |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Eicher Motors Ltd. published this content on 28 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 June 2024 11:49:49 UTC.